$0.050
-0.020 (-40.24%)At close
VSEE News
VSEE Events
VSee Health Proposes Acquisition of Healthcare Tech Assets with Over $35M Annual Revenue
VSee Health entered into a non-binding letter of intent for the proposed acquisition of certain healthcare technology and operating assets. The contemplated assets support an integrated healthcare commerce platform serving the United States clinic-based wellness market. The current annual run rate for the target assets is in excess of $35M, and EBITDA is approximately $7M. The company said, "The highly profitable proposed acquisition would bring together complementary capabilities across provider-facing sales and account management, cloud-based ordering and payment workflows, and supplier coordination and back-office operations. The platform is designed to connect suppliers, commercial organizations and clinics through an integrated operating model spanning customer development, digital commerce and order reconciliation. Consistent with an asset-light approach, the platform coordinates these workflows while suppliers and other regulated parties retain their respective product and fulfillment responsibilities. VSee believes these capabilities could complement its existing API-driven virtual care platform and broaden the digital infrastructure it can offer to healthcare organizations. The contemplated transaction is one of the strategic opportunities being evaluated as part of the Company's previously announced strategic review, which is focused on accelerating growth, strengthening VSee's competitive position and creating long-term stockholder value."
VSee Health Signs LOI for Acquisition of Healthcare Assets
VSee Health announced that it has entered into a non-binding letter of intent, LOI, for the proposed acquisition of certain healthcare technology and operating assets. The contemplated assets support an integrated healthcare commerce platform serving the United States clinic-based wellness market. The current annual run rate for the target assets is in excess of $35M, and EBITDA is approximately $7M. "We believe VSee is entering a defining chapter in the Company's evolution," said Imo Aisiku, Chief Executive Officer of VSee Health. "Our objective is not simply to complete acquisitions, but to build a larger, stronger and better-capitalized healthcare technology company with multiple engines of growth. This LOI is one example of that strategy in action. We are actively advancing additional strategic initiatives that have the potential to significantly enhance our capital resources, expand our operating platform and accelerate long-term growth. We believe the momentum we are building has the potential to reshape the future of VSee and create meaningful, sustainable value for our stockholders."
VSee Health Initiates Strategic Review to Accelerate Growth
VSee Health's Board of Directors has initiated a comprehensive strategic review aimed at pursuing transformational opportunities to accelerate growth and maximize shareholder value. The Board believes VSee has reached an important inflection point. Over the past year, the Company has strengthened its operating foundation, enhanced its technology platform and continued to expand its position in the rapidly evolving digital healthcare market. As a result, the Board believes this is the appropriate time to evaluate strategic opportunities that can accelerate growth and unlock the full value of the business. The Company is actively engaged in late-stage discussions with potential strategic partners and is pursuing these opportunities with urgency and an aggressive timeline. The Board is evaluating a broad range of strategic alternatives, with the objective of executing the strategic alternative that it believes has the greatest potential to maximize long-term shareholder value. Potential strategic alternatives under consideration may include strategic partnerships, business combinations, mergers, acquisitions, licensing transactions, capital formation initiatives and other strategic opportunities designed to strengthen the Company's competitive position and accelerate long-term growth.
VSee Health Proposes 80-for-1 Reverse Split to Protect Shareholder Value
VSee Health reaffirmed its commitment to protecting shareholder value by minimizing dilution while maintaining the financial flexibility needed to execute its growth strategy. Our Board of Directors has approved a proposed maximum of an 80-for-1 reverse stock split, subject to the completion of all applicable regulatory requirements and shareholder approvals. This action is intended to better align our capital structure with our long-term strategic objectives and support our continued Nasdaq listing. The company wants to affirm with its shareholders, the upcoming reverse split has been corrected from max of up to 250 to no more than 80 to 1. The Company confirmed that it has terminated the previously announced standby equity purchase agreement. VSee currently has no active equity financing facility expected to result in near-term dilution. As of July 6, the Company had 55,679,813 shares of common stock outstanding. Over the past 45 days, VSee has strengthened its balance sheet through non-dilutive financing and avoiding the use of any standby equity facility.
VSee Health Plans to Expand Hospital Network to 58 with AI
VSee Health shared its strategic initiatives and perspective on the role of artificial intelligence in healthcare and why enterprise telehealth platforms are well positioned to serve as the infrastructure layer for that transformation. VSee's strategic integration of AI will enhance the growth and enterprise efficiencies experienced over the last two years. The Company will look to add additional layers of AI to its hospital network both through organic development and otherwise as it takes advantage of current momentum: Hospital network expanded from 3 hospitals in 2024 to 58 hospitals in 2026; 100% of operating revenue now generated by the focused iDoc enterprise telehealth platform; Gross margins exceeding 50%; Approximately 50% annual revenue growth; Positioned for an approximately $20M revenue run-rate; Streamlined operations following the strategic separation of VSee Lab Management believes the healthcare industry is moving beyond standalone virtual visits toward integrated digital infrastructure that combines secure communications, workflow automation, clinical coordination and AI-assisted support. As hospitals consolidate point solutions in favor of unified platforms, VSee believes its hospital enterprise footprint gives it a structural advantage in delivering AI capabilities at scale.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.